People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mevion Medical Systems, Inc. | — | Biotechnology | Series C | $95.3M | $2.4B | 2012 |
| Predictive Biosciences, Inc | — | Biotechnology | Series B | $26.8M | $1.0B | 2010 |
| Gloucester Pharmaceuticals Inc | — | Biotechnology | Series B | $26.0M | $806.7M | 2009 |
| Corino Therapeutics, Inc. | — | Biotechnology | Seed | $3.5M | $154.3M | 2017 |
Jay Moorin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jay Moorin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Seth Harrison | 1 | 19 |
| Michael Greeley | 1 | 15 |
| Robert S Langer | 1 | 14 |
| David Schnell | 1 | 7 |
| Robert Wilson | 1 | 7 |
| M. James Barrett | 1 | 6 |
| Mitchell Bloom | 1 | 6 |
| James Barrett | 1 | 6 |
| Myles Greenberg | 1 | 6 |
| Thomas Dyrberg | 1 | 5 |
| Kenneth Gall | 1 | 5 |
| Bijan Salehizadeh | 1 | 5 |
| Vikram Lamba | 1 | 4 |
| Timothy McInerney | 1 | 4 |
| Anders Hove | 1 | 4 |
| Alan B. Colowick | 1 | 3 |
| Donald J Hayden | 1 | 3 |
| Martin Vogelbaum | 1 | 3 |
| Kim Blickenstaff | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.